Latest stories on BLRX
BioLineRx and Hemispherian to Showcase GLIX1 Glioblastoma Data and Trial Design at EANO 2026
TipRanks63 · neutralproduct/pr
BioLineRx Ltd. (BLRX) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
BioLineRx Raises $3.75 Million in August Registered Direct Offering and Warrant Deal
TipRanks24 · bearishgeneral
BioLineRx Advances GLIX1 Oncology Program and Posts Q2 2026 Results
TipRanks56 · neutralgeneral
BioLineRx reports Q2 EPS 0c vs 0c last year
The Fly50 · neutralearnings
Options Volatility and Implied Earnings Moves Today, August 31, 2026
TipRanks55 · neutralearnings
BioLineRx GAAP EPS of $0.00, revenue of $0.3M
Seeking Alpha34 · bearishearnings
BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update
PR Newswire56 · neutralproduct/pr
Here are the major earnings before the open Monday
Seeking Alpha50 · neutralearnings
BioLineRx Q2 Earnings Preview
Seeking Alpha56 · neutralearnings
BioLineRx stock falls on $3.75M share offering plan
Investing.com Markets28 · bearishgeneral
BioLineRx targets $3.75M raise via direct offering with new ADS warrants
Seeking Alpha24 · bearishgeneral
BioLineRx prices 1.35M ADSs at $2.78 in registered direct offering
The Fly28 · bearishgeneral
BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private Placement
PR Newswire28 · bearishgeneral
BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private Placement
StockTitan28 · bearishgeneral
BioLineRx to Report Second Quarter 2026 Results on August 31, 2026
PR Newswire50 · neutralgeneral
BioLineRx Sets September 23, 2026 Shareholders Meeting to Boost Capital and Approve New Equity Awards
TipRanks48 · neutralgeneral
BioLineRx Ltd. (BLRX) Q1 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
BioLineRx Shares Advance After First Patient Enrolled in GLIX1 Cancer Study (BLRX)
Yahoo Top63 · neutralproduct/pr
BioLineRx Kicks Off GLIX1 Clinical Trial as Q1 2026 Loss Widens on Higher R&D Spend
TipRanks53 · neutralgeneral
BioLineRx GAAP EPS of $0.00 beats by $1.04, revenue of $0.48M beats by $0.14M
Seeking Alpha68 · bullishearnings
BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
PR Newswire56 · neutralproduct/pr